YU45852B - Postupak za dobijanje peptida - Google Patents

Postupak za dobijanje peptida

Info

Publication number
YU45852B
YU45852B YU152881A YU152881A YU45852B YU 45852 B YU45852 B YU 45852B YU 152881 A YU152881 A YU 152881A YU 152881 A YU152881 A YU 152881A YU 45852 B YU45852 B YU 45852B
Authority
YU
Yugoslavia
Prior art keywords
procedure
obtaining peptides
sub
peptides
obtaining
Prior art date
Application number
YU152881A
Other languages
English (en)
Other versions
YU152881A (en
Inventor
G. Heavner
Original Assignee
Ortho Pharmaceutical Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22576099&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU45852(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Pharmaceutical Corp. filed Critical Ortho Pharmaceutical Corp.
Publication of YU152881A publication Critical patent/YU152881A/xx
Publication of YU45852B publication Critical patent/YU45852B/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0819Tripeptides with the first amino acid being acidic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/66Thymopoietins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06086Dipeptides with the first amino acid being basic
    • C07K5/06095Arg-amino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

POSTUPAK ZA DOBIJANJE PEPTIDA H-ARG-X-Z-Y-TYR-R gde X je LYS a Y je VAL ili X i Y su oba SAR, Z je ASP ili GLU i R je OH ili NH2, naznacen time, sto obuhvata a) obrazovanje fragmenta I H-Y-TYR-R' pomocu: i) zastite alfa-amino grupe Y amino kiseline tako sto ova reaguje sa reagensom koji uvodi zastitnu grupu T; ii) aktivaciju zasticene grupe iz faze i) u odnosu na nukleofilni napad na karboksi grupu pomocu amina, tako da se gradi karboksi aktivirana zasticena aminokiselina; iii) reakcije pomenute karboksi-aktivirane zasticene grupe Y sa TYR-R'; i iv) odvajanje zasticene grupe T, tako da se obrazuje fragment I; b) obrazovanje fragmenta II, alfa-T-(epsilon-T")X-omega-U-Z-OH pomocu i) obrazovanja fragmenta omega-U-Z-OH, gde U je zastitna grupa na omega karboksi-grupi Z aminokiseline; ii) zastite alfa-amino grupe (i ako X je LYS, epsilon-amino grupe) X aminokiseline tako sto ova reaguje sa reagensom (ima) koji uvode zastitnu (e) grupu (e) Ti (T"); iii) aktivacije zasticene grupe X iz faze ii) u odnosu na nukleofilni napad na karboksi grupi pomocu amina, tako da se obrazuje karboksi-aktivirana zasticena X aminokiselina; iv) reagovanja pomenute karboksi-aktivirane zasticene X aminokiseline sa omega-U-Z-OH fragmentom radi dobivanja fragmenta II; c) reakciju fragmenta I i II, tako da se obrazuje fragment III T-(epsilon-T")X-omega-U-Z-Y-TYR-R' d) odvajanje T zastitne grupe iz fragmenta II tako da se obrazuje fragment IIIA H-(epsilon-T")X-omega-U-Z-Y-TYR-R' e) obrazovanje fragmenta alfa-T-omega-T'-ARG, gde T je zastitna grupa na alfa-amino grupi L-arginina i T' je zastitna grupa na guanidino grupi l-arginina; f) reakciju fragmenta IIA sa fragmentom alfa-T-omega-T'-ARG tako da se obrazuje ALFA-t-OMEGA-t'-arg-(epsilon-T')X-omega-U-Z-Y-TYR-R' g) odvajanje U,T,T' i T" grupa tako da se obrazuje peptid H-ARG-X-Z-Y-TYR-R i h) izolovanje i preciscavanje dobivenog peptida; pri cemu su u datim formulama; T i T" svaki clan izabran iz grupe koja sadrzi: fenil, tolil, ksilil, adamantil, alil, betacijanoetil, fluorofenilmetil, benzil, gde je fenil prsten supstituisan sa od jedan do tri clana izabrana iz grupe koja sadrze halo, nitro, nizialkil, i nizialkoksi, diizopropilmetil, difenilmetil, cikloheksil, cikopentil, vinil, t-butil, t-amil, dimetiltrifluorometilrnetil; ili dimetilbifenilmetil; nizialkil sa dva do cetiri ugljenika ili nizialkil sa jedan do cetiri ugljenika supstituisan sa jednom do pet halo grupa; V c) R3O-P- gde je V S ili O i R3 i R4 OR4 su svaki benzil ili nizi alkil; d) gde su R5 i R6 uzeti pojedinacno svaki nizialkil ili su R5 i R6 uzeti zajednicki -CH2-C-CH2- gde su R7 i svaki pod uslovom da je T monodentat kada je X SAR; U je benzil ili benzil u kojem je fenil grupa supstituisana sa jednim do tri clana pri cemu je svaki izabran od halo, nitro, C1-C3 nizialkil i C1-C3 nizialkoksi, i O T' je clan izabran iz grupe koja sadrzi R1-OC- gde je R1 kao sto je definisano gore, nitro, hlorhidrat, P-metoksibenzilsulfonil i tozil. Prijava sadrzi jos 14 patentnih
YU152881A 1980-06-17 1981-06-17 Postupak za dobijanje peptida YU45852B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/160,241 US4298523A (en) 1980-06-17 1980-06-17 Methods and compositions for preparation of H-ARG-X-Z-Y-TYR-R

Publications (2)

Publication Number Publication Date
YU152881A YU152881A (en) 1984-02-29
YU45852B true YU45852B (sh) 1992-09-07

Family

ID=22576099

Family Applications (1)

Application Number Title Priority Date Filing Date
YU152881A YU45852B (sh) 1980-06-17 1981-06-17 Postupak za dobijanje peptida

Country Status (19)

Country Link
US (1) US4298523A (sh)
EP (3) EP0565148A2 (sh)
JP (3) JPS5728036A (sh)
AT (2) ATE24183T1 (sh)
AU (3) AU562807B2 (sh)
CA (6) CA1188297A (sh)
DE (2) DE3175701D1 (sh)
DK (3) DK151968C (sh)
ES (3) ES503012A0 (sh)
FI (1) FI79329C (sh)
GR (1) GR74546B (sh)
IE (3) IE62213B1 (sh)
IL (7) IL72393A (sh)
NO (3) NO161744C (sh)
NZ (1) NZ197294A (sh)
PH (2) PH16501A (sh)
PT (1) PT73201B (sh)
YU (1) YU45852B (sh)
ZA (1) ZA814061B (sh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4369137A (en) * 1980-06-17 1983-01-18 Ortho Pharmaceutical Corporation N-Protected pentapeptides useful as intermediates in the preparation of thymopoietin pentapeptide
US4499079A (en) * 1982-11-18 1985-02-12 E. R. Squibb & Sons, Inc. Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides
DE3401545A1 (de) * 1983-08-03 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue peptide mit immunstimulierender wirkung, verfahren zu deren herstellung und deren verwendung
US4505853A (en) * 1983-11-18 1985-03-19 Ortho Pharmaceutical Corporation Enzyme-resistant immunomodulatory peptides
AU602483B2 (en) * 1985-01-18 1990-10-18 Immunetech Pharmaceuticals Immunoregulatory peptides
US4749690A (en) * 1986-01-27 1988-06-07 Ortho Pharmaceutical Corporation Treatment of allergy with thymopentin
US4732970A (en) * 1986-06-13 1988-03-22 American Cyanamid Company Antitumor amino acid and peptide derivatives of 1,4-bis(aminoalkyl and hydroxy-aminoalkyl)amino)-5,8-dihydroxyanthraquinones
US5200506A (en) * 1987-03-19 1993-04-06 Eniricerche S.P.A. Process for preparing new thymopentin retro-inverso analogs and fragments thereof and the intermediates obtained therein
HU199878B (en) * 1987-06-19 1990-03-28 Berlin Chemie Veb Process for producing acylated splenopentynes and pharmaceutical compositions comprising such compounds as active ingredient
US5656601A (en) * 1987-06-19 1997-08-12 Berlin-Chemie Ag Acylated splenopentins, methods for their synthesis and their use
FR2622587B1 (fr) * 1987-10-30 1990-12-21 Inst Vaisseaux Sang Peptide lysyl-arginyl-aspartyl-serine et ses applications en tant que medicament, notamment antithrombotique
NZ229004A (en) * 1988-05-19 1993-09-27 Immunobiology Res Inst Inc Tetrapeptides having t cell helper acitivity
JPH01264767A (ja) * 1988-11-17 1989-10-23 G N Tool Kk 砥石自動交換cnc工具研削盤
CN101168560B (zh) * 2006-10-23 2012-09-05 江苏正大天晴药业股份有限公司 N-取代肽酰胺,其药物组合物与用途
EP2376101B1 (en) 2008-12-29 2015-12-02 Trevena, Inc. Beta-arrestin effectors and compositions and methods of use thereof
JP2017506235A (ja) 2014-02-07 2017-03-02 トレベナ・インコーポレイテッドTrevena, Inc. ベータ−アレスチンエフェクターの結晶性および非晶質形態
AU2015264367A1 (en) 2014-05-19 2016-12-15 Trevena, Inc. Synthesis of Beta-Arrestin Effectors

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317559A (en) * 1963-08-23 1967-05-02 American Cyanamid Co alpha-amino acid esters of n-hydroxysuccinimide and preparation and use in peptide synthesis
DE1593830A1 (de) * 1967-05-24 1971-03-11 Akad Wissenschaften Ddr Verfahren zur Herstellung von Peptiden
US3560503A (en) * 1968-09-18 1971-02-02 Council Scient Ind Res Di-lower alkyl-substituted octahydropyrazinopyrimidinones
JPS4826010B1 (sh) * 1969-11-11 1973-08-03
US3997516A (en) * 1974-07-04 1976-12-14 Takeda Chemical Industries, Ltd. Method for protecting guanidino group and restoring the same
DE2544348C3 (de) * 1975-10-03 1979-12-13 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen L-Leucin-13-Motilin, Verfahren zu dessen Herstellung und dasselbe enthaltendes Mittel
US4190646A (en) * 1975-11-11 1980-02-26 Sloan-Kettering Institute For Cancer Research Polypeptide compositions and methods
SE446867B (sv) * 1977-11-15 1986-10-13 Sloan Kettering Inst Cancer Sett att framstella en polypeptid med formaga att inducera differentiering av t-lymfocyter men inte av komplementreceptor (cr?72+) b-lymfocyter
US4215112A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Tripeptides and methods
US4215111A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Peptides having ubiquitin-like activity
CA1156220A (en) * 1979-04-26 1983-11-01 George Heavner Method and composition for preparation of h-sar-lys-sar-gln-nh.sub.2
DE2938420A1 (de) * 1979-09-22 1981-04-09 Hoechst Ag, 6000 Frankfurt Neue peptide und verfahren zu ihrer herstellung
US4309340A (en) * 1980-03-31 1982-01-05 American Home Products Corporation Polypeptide compositions

Also Published As

Publication number Publication date
DK415485D0 (da) 1985-09-12
ES8303298A1 (es) 1983-02-01
AU4566785A (en) 1985-11-07
NZ197294A (en) 1984-12-14
CA1315041C (en) 1993-03-23
AU4566885A (en) 1985-11-07
PH21622A (en) 1987-12-11
NO166532C (no) 1991-08-07
IL72393A (en) 1985-06-30
IE811336L (en) 1981-12-17
PT73201A (en) 1981-07-01
US4298523A (en) 1981-11-03
EP0042291A2 (en) 1981-12-23
CA1188297A (en) 1985-06-04
EP0144103A2 (en) 1985-06-12
NO166532B (no) 1991-04-29
EP0144103A3 (en) 1988-08-10
NO900294L (no) 1981-12-18
GR74546B (sh) 1984-06-29
AU4566685A (en) 1985-11-07
DK154653C (da) 1989-05-01
YU152881A (en) 1984-02-29
ES8304541A1 (es) 1983-03-01
EP0565148A3 (sh) 1994-02-09
FI811883L (fi) 1981-12-18
NO164245B (no) 1990-06-05
AU562807B2 (en) 1987-06-18
DK154437C (da) 1989-04-10
JPH01308297A (ja) 1989-12-12
ES8207513A1 (es) 1982-10-01
IE62614B1 (en) 1995-02-22
JPH01308298A (ja) 1989-12-12
NO161744B (no) 1989-06-12
IE62213B1 (en) 1995-01-11
IL63108A (en) 1985-06-30
IL72392A0 (en) 1984-11-30
ATE24183T1 (de) 1986-12-15
IL72392A (en) 1985-06-30
ES512721A0 (es) 1983-02-01
NO812035L (no) 1981-12-18
DK151968B (da) 1988-01-18
DE3175701D1 (en) 1987-01-22
DK415485A (da) 1985-09-12
PH16501A (en) 1983-11-04
ES512722A0 (es) 1983-03-01
DK227787A (da) 1987-05-04
IL72394A (en) 1985-06-30
CA1315042C (en) 1993-03-23
CA1282550C (en) 1991-04-02
DK151968C (da) 1988-09-19
NO164245C (no) 1990-09-12
NO161744C (no) 1989-09-20
DK263781A (da) 1981-12-18
NO885646L (no) 1981-12-18
FI79329B (fi) 1989-08-31
EP0042291B1 (en) 1986-12-10
IE940518L (en) 1981-12-17
JPS5728036A (en) 1982-02-15
JPH0357118B2 (sh) 1991-08-30
DE3177306T2 (de) 1994-06-30
EP0042291A3 (en) 1982-03-31
ES503012A0 (es) 1982-10-01
FI79329C (fi) 1989-12-11
IE881720L (en) 1981-12-17
EP0144103B1 (en) 1993-12-29
IL63108A0 (en) 1981-09-13
CA1285099C (en) 1991-06-18
DK154437B (da) 1988-11-14
ZA814061B (en) 1983-01-26
NO900294D0 (no) 1990-01-22
DK227787D0 (da) 1987-05-04
CA1315040C (en) 1993-03-23
EP0565148A2 (en) 1993-10-13
PT73201B (en) 1983-04-26
AU562808B2 (en) 1987-06-18
JPH0354957B2 (sh) 1991-08-21
AU563303B2 (en) 1987-07-02
JPH0355480B2 (sh) 1991-08-23
DE3177306D1 (de) 1994-02-10
ATE99327T1 (de) 1994-01-15
IL72393A0 (en) 1984-11-30
NO885646D0 (no) 1988-12-20
IL72394A0 (en) 1984-11-30
DK154653B (da) 1988-12-05

Similar Documents

Publication Publication Date Title
YU45852B (sh) Postupak za dobijanje peptida